相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
B. You et al.
BRITISH JOURNAL OF CANCER (2013)
EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
Constantine Alifrangis et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations
N. J. Sebire et al.
PLACENTA (2013)
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy
C. Lybol et al.
ANNALS OF ONCOLOGY (2012)
Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
R. Agarwal et al.
BRITISH JOURNAL OF CANCER (2012)
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009
A. Sita-Lumsden et al.
BRITISH JOURNAL OF CANCER (2012)
Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
C. Lybol et al.
GYNECOLOGIC ONCOLOGY (2012)
Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study
Roshan Agarwal et al.
LANCET (2012)
Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study
Raymond J. Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
What a difference an egg makes
Rosemary A. Fisher et al.
LANCET (2011)
The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l-1
S. McGrath et al.
BRITISH JOURNAL OF CANCER (2010)
Gestational trophoblastic disease
Michael J. Seckl et al.
LANCET (2010)
Does chest CT matter in the staging of GTN?
Suzanne Darby et al.
GYNECOLOGIC ONCOLOGY (2009)
Current management of gestational trophoblastic diseases
Ross S. Berkowitz et al.
GYNECOLOGIC ONCOLOGY (2009)
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
Peter Schmid et al.
LANCET (2009)
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
J. Wang et al.
ANNALS OF ONCOLOGY (2008)
The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies
Rosemary A. Fisher et al.
GYNECOLOGIC ONCOLOGY (2007)
Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine
M. Bianconi et al.
GYNECOLOGIC ONCOLOGY (2007)
Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mode: evidence for revised protocol of a UK regional trophoblastic disease unit
N. J. Sebire et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination
D. J. Fowler et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Gestational trophoblastic diseases:: 3.: Human chorionic gonadotropin-free β-subunit, a reliable marker of placental site trophoblastic tumors
Laurence A. Cole et al.
GYNECOLOGIC ONCOLOGY (2006)
Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
T Turan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease
NE van Trommel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
LM El-Helw et al.
BRITISH JOURNAL OF CANCER (2005)
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia
JR Lurain et al.
GYNECOLOGIC ONCOLOGY (2005)
Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery
Z Pandian et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Routine terminations of pregnancy - should we screen for gestational trophoblastic neoplasia?
MJ Seckl et al.
LANCET (2004)
Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin
NJ Sebire et al.
LANCET (2002)
Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
IA McNeish et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
EI Kohorn
GYNECOLOGIC ONCOLOGY (2002)
分享论文
